GGrantIndex
Sort

16,300 grants matching fatty liver disease

Lipid-Mediated Control of Acetyl-CoA Metabolism in the Pathogenesis of NAFLD

$749,458
David E Cohen · Brigham And Women'S Hospital · R01 · FY2024 · DK

Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers

$749,248
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Caregivers as the Agent of Change for Childhood Obesity and Chronic Disease Risk Among Latino Families

$748,957
Kerri N Boutelle · Children'S Hospital Of Los Angeles · P50 · FY2022 · MD

Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophy

$748,650
Grace A McComsey · Case Western Reserve University · R01 · FY2023 · DK

A vascularized patient-derived iPSC liver acinus microphysiology system as an innovative precision medicine platform for optimizing clinical trial design for nonalcoholic fatty liver disease

$748,638
D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UG3 · FY2020 · TR

Using genetic variation to study biology of blood lipids & coronary heart disease

$748,631
Gina Marie Peloso · Boston University Medical Campus · R01 · FY2022 · HL

Covalent Chemistry on Nanosubstrates Enables Molecular Analysis of Purified Extracellular Vesicles in Hepatocellular Carcinoma

$748,485
Hsian-Rong Tseng · University Of California Los Angeles · R01 · FY2024 · CA

Food Prescriptions to Promote Affordable Diets that Meet RDAs Among Multi-Generational Latino Households

$748,389
Deborah A Cohen · Children'S Hospital Of Los Angeles · P50 · FY2023 · MD

TOPMed Omics of Type 2 Diabetes and Quantitative Traits

$747,659
Alisa Knodle Manning · Massachusetts General Hospital · UM1 · FY2023 · DK

Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B

$747,013
Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK

Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism

$746,941
Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2015 · AA

Imaging the Vascular Consequences of Lipid Deposition

$746,491
James Athur Hamilton · Boston University Medical Campus · P50 · FY2009 · HL

Using genetic variation to study biology of blood lipids & coronary heart disease

$746,085
Gina Marie Peloso · Boston University Medical Campus · R01 · FY2023 · HL

The physiological and molecular function of choline transport in health and metabolic disease

$746,070
Kivanc Birsoy · Rockefeller University · R01 · FY2024 · DK

Genetic Susceptibility to Adverse Metabolic Consequences of Obesity

$745,750
Jonathan C Cohen · Ut Southwestern Medical Center · RL1 · FY2009 · HL

Genetic Susceptibility to Adverse Metabolic Consequences of Obesity

$745,750
Jonathan C Cohen · Ut Southwestern Medical Center · RL1 · FY2008 · HL

Genetic Susceptibility to Adverse Metabolic Consequences of Obesity

$745,750
Jonathan C Cohen · Ut Southwestern Medical Center · RL1 · FY2007 · HL

HT Image Assay of Lipid Droplet Formation in Human Adipocytes

$745,749
Patrick M McDonough · Vala Sciences, Inc. · R44 · FY2009 · DK

Enhancing immune regulation in gene therapy for hemophilia

$745,423
Roland W. Herzog · Indiana University Indianapolis · R01 · FY2025 · HL

Exosomal biomarkers for the early detection of hepatocellular carcinoma

$745,286
Ajay Goel · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA

Targeting the gut-liver axis in cardiovascular disease

$745,258
Thomas A Vallim · University Of California Los Angeles · R01 · FY2023 · HL

Targeting the gut-liver axis in cardiovascular disease

$745,258
Thomas A Vallim · University Of California Los Angeles · R01 · FY2025 · HL

Molecular Mechanisms of Inflammation, Steatosis and Hepatic Insulin Resistance

$745,195
Jerrold M Olefsky · University Of California, San Diego · R24 · FY2011 · DK

Regulation of NF-Kappa B

$745,119
Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2010 · AI

Quantitative Magnetic Resonance Imaging Phantoms

$745,064
Jean H. Brittain · Calimetrix, Llc · R44 · FY2020 · EB